Country: Ireland
Language: English
Source: HPRA (Health Products Regulatory Authority)
CICLOSPORIN
Le Vet Beheer B.V.
QL04AA01
CICLOSPORIN
50 Mg/Ml
Oral Solution
POM
Canine, Feline
Ciclosporin
Miscellaneous
Authorised
2013-07-19
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE VETERINARY MEDICINAL PRODUCT Sporimune 50 mg/ml oral solution for cats and dogs 2 QUALITATIVE AND QUANTITATIVE COMPOSITION 3 PHARMACEUTICAL FORM Oral solution. Colourless to yellowish oily solution 4 CLINICAL PARTICULARS 4.1 TARGET SPECIES Dog, cat. 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES Treatment of chronic manifestations of atopic dermatitis in dogs. Symptomatic treatment of chronic allergic dermatitis in cats. 4.3 CONTRAINDICATIONS Do not use in cases of hypersensitivity to the active substance or any of the excipients. Do not use in dogs less than six months of age or less than 2 kg in weight. Do not use in cases with a history of malignant disorders or progressive malignant disorders. Do not vaccinate with a live vaccine during treatment or within a two-week interval before or after treatment. (see also sections 4.5 “Special precautions for use” and 4.8 “Interaction with other medicinal products”). Do not use in cats infected with FeLV or FIV. 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES Consideration should be given to the use of other measures and/or treatments to control moderate to severe pruritus when initiating therapy with ciclosporin. Per ml: ACTIVE SUBSTANCES: Ciclosporin 50 mg EXCIPIENTS: Ethanol, anhydrous (E-1510) 100 mg all-rac-a-Tocopherol acetate (E-307) 1.00 mg For a full list of excipients, see section 6.1. HEALTH PRODUCTS REGULATORY AUTHORITY ________________________________________________________________________________________________________________________ _Date Printed 08/12/2016_ _CRN 7024577_ _page number: 1_ 4.5 SPECIAL PRECAUTIONS FOR USE SPECIAL PRECAUTIONS FOR USE IN ANIMALS Clinical signs of atopic dermatitis in dogs and allergic dermatitis in cats such as pruritus and skin inflammation are not sp Read the complete document